semaglutide weight loss port st lucie Medical Semaglutide Treatment in Port Saint

Importantly, Rybelsus is not indicated for type 1 diabetes, is not a substitute for insulin, and should not be used alongside other GLP-1 receptor agonists

SELECT Landmark Study in Detail The SELECT trial enrolled patients with a mean BMI of 33.3 and preexisting cardiovascular disease (prior myocardial infarction, stroke, or peripheral arterial disease) but no diabetes history

Some people may experience mild side effects for longer than others

Sustainable Results with Lifestyle Support

Results: Across completed head-to-head randomized trials, tirzepatide consistently achieved greater reductions in body weight, and HbA1c than semaglutide in individuals with obesity or T2DM